Loading...
Chia Tai Enterprises International Limited
CAIHF•PNK
Healthcare
Biotechnology
$0.28
$0.00(0.00%)
Chia Tai Enterprises International Limited (CAIHF) Financial Performance & Income Statement Overview
Review Chia Tai Enterprises International Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
76.89%
↑ 76.89%
Operating Income Growth
429.51%
↑ 429.51%
Net Income Growth
337.45%
↑ 337.45%
Operating Cash Flow Growth
100.00%
↑ 100.00%
Operating Margin
3.63%
↑ 3.63%
Gross Margin
15.90%
↑ 15.90%
Net Profit Margin
3.63%
↑ 3.63%
ROE
4.84%
↑ 4.84%
ROIC
4.03%
↑ 4.03%
Chia Tai Enterprises International Limited (CAIHF) Income Statement & Financial Overview
Review Chia Tai Enterprises International Limited's (CAIHF) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $137.19M | $62.58M | $53.33M | $54.65M |
| Cost of Revenue | $119.33M | $49.50M | $43.85M | $46.14M |
| Gross Profit | $17.86M | $13.08M | $9.48M | $8.51M |
| Gross Profit Ratio | $0.13 | $0.21 | $0.18 | $0.16 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $10.69M | $9.30M | $9.07M | $8.69M |
| Operating Expenses | $10.69M | $9.30M | $9.07M | $6.03M |
| Total Costs & Expenses | $130.01M | $58.80M | $52.92M | $52.17M |
| Interest Income | $0.00 | $0.00 | $54000.00 | $609000.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $1.58M | $1.58M | $1.94M | $1.58M |
| EBITDA | $8.76M | $5.36M | $2.35M | $1.40M |
| EBITDA Ratio | $0.06 | $0.09 | $0.04 | $0.03 |
| Operating Income | $7.17M | $3.78M | $408000.00 | -$184000.00 |
| Operating Income Ratio | $0.05 | $0.06 | $0.008 | -$0.003 |
| Other Income/Expenses (Net) | $1.48M | $63000.00 | $1.27M | $2.06M |
| Income Before Tax | $8.65M | $3.84M | $1.68M | $1.88M |
| Income Before Tax Ratio | $0.06 | $0.06 | $0.03 | $0.03 |
| Income Tax Expense | $340000.00 | $970000.00 | $398000.00 | $426000.00 |
| Net Income | $6.91M | $2.30M | $974000.00 | $989000.00 |
| Net Income Ratio | $0.05 | $0.04 | $0.02 | $0.02 |
| EPS | $0.03 | $0.00 | $0.03 | $0.03 |
| Diluted EPS | $0.03 | $0.00 | $0.03 | $0.03 |
| Weighted Avg Shares Outstanding | $253.34M | $253.34M | $253.33M | $253.33M |
| Weighted Avg Shares Outstanding (Diluted) | $253.33M | $253.33M | $253.33M | $253.33M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan